PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy (CRT) in patients with stage III, locally advanced, unresectable NSCLC Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Paz-Ares, L.; Villegas, A.; Daniel, D.; Baz, D. V.; Murakami, S.; Hui, R.; Yokoi, T.; Chiappori, A.; Lee, K. H.; de Wit, M.; Cho, B. C.; Bourhaba, M.; Quantin, X.; Tokito, T.; Mekhail, T.; Planchard, D.; Jiang, H.; Huang, Y.; Dennis, P. A.; Ozguroglu, M.

authors

Publication Date

  • September 1, 2017

webpage

published in

category

volume

  • 28